Skip to content

Comparison of treatment with Repetitive Trans cranial Magnetic Stimulation with medication, with medication alone in obsessive-compulsive disordered

Comparison of treatment with Repetitive Trans cranial Magnetic Stimulation with medication, with medication alone in obsessive-compulsive disordered resistance to medication

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190622043979N1
Enrollment
30
Registered
2019-06-26
Start date
2019-07-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive compulsive disorder resistance to drug therapy. Obsessive-compulsive disorder

Interventions

Intervention 1: Intervention group: Therapeutic drug for 3 weeks and 5 times per week with a frequency of 1 Hz for 20 minutes (1200 pulses / day). Intervention 2: Control group: Therapeutic drug plus

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18-60 A previous history of OCD for at least one year, treated with the first two Obsessive drugs approved by the FDA, has not been improved and is right-handed. In the YBOCS questionnaire, the score was more than or equal to 16, and in the Beck questionnaire the score was not higher than 17.

Exclusion criteria

Exclusion criteria: Accompanied with other psychiatric disorders History of seizure or epileptic seizures Beck questionnaire score above 17 Pregnancy Substance abuse based on biographie History of severe head trauma or severe neurological complications Metal implant or pace maker

Design outcomes

Primary

MeasureTime frame
Improvement. Timepoint: Obsessive compulsive disorder will be assessed in both groups of A and B after 3 weeks. Method of measurement: At the end of the study, the mean scores of the questionnaire, as well as the clinical observations and clinical assessments of the questioner, were compared in both groups compared to the beginning of the study and the other group in order to determine the effectiveness of each regimen independently and in comparison with others as well as the rate of remission.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazal Jahan Bakhsh

Qazvin University of Medical Sciences

dralihsj52@gmail.com+98 28 3356 5712

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026